- Home
- ATRC vs QQQX Comparison
ATRC vs QQQX Comparison
Compare ATRC & QQQX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRC
- QQQX
- Stock Information
- Founded
- ATRC 2000
- QQQX 2007
- Country
- ATRC United States
- QQQX United States
- Employees
- ATRC N/A
- QQQX N/A
- Industry
- ATRC Medical/Dental Instruments
- QQQX Finance Companies
- Sector
- ATRC Health Care
- QQQX Finance
- Exchange
- ATRC Nasdaq
- QQQX Nasdaq
- Market Cap
- ATRC 1.6B
- QQQX 1.3B
- IPO Year
- ATRC 2005
- QQQX N/A
- Fundamental
- Price
- ATRC $33.13
- QQQX $26.99
- Analyst Decision
- ATRC Strong Buy
- QQQX
- Analyst Count
- ATRC 9
- QQQX 0
- Target Price
- ATRC $52.00
- QQQX N/A
- AVG Volume (30 Days)
- ATRC 618.7K
- QQQX 127.6K
- Earning Date
- ATRC 10-29-2025
- QQQX 01-01-0001
- Dividend Yield
- ATRC N/A
- QQQX 7.03%
- EPS Growth
- ATRC N/A
- QQQX N/A
- EPS
- ATRC N/A
- QQQX N/A
- Revenue
- ATRC $518,304,999.00
- QQQX N/A
- Revenue This Year
- ATRC $16.90
- QQQX N/A
- Revenue Next Year
- ATRC $12.29
- QQQX N/A
- P/E Ratio
- ATRC N/A
- QQQX N/A
- Revenue Growth
- ATRC 15.80
- QQQX N/A
- 52 Week Low
- ATRC $28.29
- QQQX $20.27
- 52 Week High
- ATRC $43.11
- QQQX $25.99
- Technical
- Relative Strength Index (RSI)
- ATRC 45.22
- QQQX 36.23
- Support Level
- ATRC $31.12
- QQQX $27.09
- Resistance Level
- ATRC $33.98
- QQQX $27.70
- Average True Range (ATR)
- ATRC 1.80
- QQQX 0.40
- MACD
- ATRC -0.00
- QQQX -0.14
- Stochastic Oscillator
- ATRC 39.16
- QQQX 7.74
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
About QQQX Nuveen NASDAQ 100 Dynamic Overwrite Fund Shares of Beneficial Interest
Nuveen NASDAQ 100 Dynamic Overwrite Fund is a closed-end management investment company. Its investment objective is to seek an attractive total return with less volatility than the Nasdaq 100 Index. Under normal circumstances, the Fund will invest at least 80% of its Assets in an equity portfolio made up of securities comprising the Nasdaq 100 Index (or securities that have economic characteristics that are similar to those securities comprising the Nasdaq 100 Index) that seeks to substantially replicate price movements of the Nasdaq 100 Index and is designed to support the Fund's option strategy.